Evaluation of current status of cardiovascular disease treatment by province in China-data from China Cardiovascular Health Index

ObjectiveTo evaluate the current status of cardiovascular disease treatment in China.

MethodsThe materials and data used in this study were from the research results of Cardiovascular Health Index (CHI) (2017) in China. Fifteen indicators from the dimension of "disease treatment" of CHI (2017) were selected to measure and analyze the conditions of 31 provinces, autonomous regions and municipalities in China, excluding Hong Kong, Macao and Taiwan. The scores of CHI in the treatment of cardiovascular diseases in China were ranked and compared by province. The full score of each index in CHI "disease treatment" dimension was 100, and higher score indicated better treatment of cardiovascular diseases.

ResultsIn 2017, the average score of cardiovascular disease treatment was 44.04 in China. Area specific analysis results showed that the score of cardiovascular disease treatment in southern China was 47.29, which was higher than that in northern China (39.51). The score in eastern China was 46.93, higher than that in central China (41.08) and in western China (42.48). The highest score was in Beijing (62.01), followed by Zhejiang (61.73), Shanghai (61.72), Hunan (60.96) and Hainan (60.39). The lowest score was in Ningxia (27.11), while other provinces with lower scores were Liaoning (28.16), Anhui (34.56), Yunnan (35.09) and Inner Mongolia (35.23).

ConclusionThe performance of cardiovascular disease treatment varied with area in China, characterized by the better treatment in southern China than in the northern China, and the better treatment in eastern China and southern coastal area than in other areas.